ModeX Therapeutics is a clinical-stage biopharmaceutical company developing innovative treatments for cancer and infectious diseases. They develop multispecific biologics, a new class of drugs that combines the power of multiple antibodies or other biologics into a single molecule. This multi-pronged approach allows ModeX to target several dysfunctional pathways in complex diseases, potentially leading to more effective therapies. Using their MSTAR platform they can develop multispecific antibodies that target up to six pathways. Their pipeline focuses on treatment of various solid tumors by targeting multiple tumor antigens and potentially overcoming resistance mechanisms, as well as creating treatments against serious viral threats by attacking different aspects of the virus life cycle.

ModeX Therapeutics

Founded: 2020
Location: Natick, MA
Employee range: 11 - 50
Clinical stage: Clin0
Therapy area: solid tumors
Drug types: ONC
Lead product: HIV antibody

Drug notes:

About:

Jobs: